Bosentan
生产企业:Actelion ltd
Bosentan is a dual endothelin receptor antagonist used to treat pulmonary arterial hypertension.
Bosentan is a dual endothelin receptor antagonist used to treat pulmonary arterial hypertension.
Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET and ET receptors in the endothelium and vascular smooth muscle. It displays a slightly higher affinity towards ET receptors than ET receptors. ET-1 concentrations are elevated in plasma and lung tissue of patients with pulmonary arterial hypertension, suggesting a pathogenic role for ET-1 in this disease. Bosentan is a specific and competitive antagonist at endothelin receptor types ET and ET.
Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms).
共 3 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。